These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9536003)

  • 1. Differential atrial versus ventricular activities of class III potassium channel blockers.
    Baskin EP; Lynch JJ
    J Pharmacol Exp Ther; 1998 Apr; 285(1):135-42. PubMed ID: 9536003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
    Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
    Knobloch K; Brendel J; Rosenstein B; Bleich M; Busch AE; Wirth KJ
    Med Sci Monit; 2004 Jul; 10(7):BR221-8. PubMed ID: 15232496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of increased extracellular potassium and pacing frequency on the class III activities of methanesulfonanilide IKr blockers dofetilide, D-sotalol, E-4031, and MK-499.
    Baskin EP; Lynch JJ
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):199-208. PubMed ID: 7526051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of binding to rapidly activating delayed rectifier K+ channel, IKr, and effects on myocardial refractoriness for class III antiarrhythmic agents.
    Lynch JJ; Baskin EP; Nutt EM; Guinosso PJ; Hamill T; Salata JJ; Woods CM
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):336-40. PubMed ID: 7752661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents.
    Fermini B; Jurkiewicz NK; Jow B; Guinosso PJ; Baskin EP; Lynch JJ; Salata JJ
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):259-71. PubMed ID: 7475051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preserved effects of potassium channel blockers in the pacing-induced remodeled canine atrium: a comparison between E4031 and azimilide.
    Shiroshita-Takeshita A; Mitamura H; Sato T; Shinagawa K; Kurita Y; Kanki H; Takatsuki S; Hara M; Ogawa S
    J Cardiovasc Pharmacol; 2003 May; 41(5):678-85. PubMed ID: 12717097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties.
    Nattel S; Liu L; St-Georges D
    Cardiovasc Res; 1998 Mar; 37(3):627-35. PubMed ID: 9659446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: considerations on the mechanism of reverse rate-dependent action potential prolongation.
    Groh WJ; Gibson KJ; Maylie JG
    J Cardiovasc Electrophysiol; 1997 May; 8(5):529-36. PubMed ID: 9160229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azimilide (NE-10064) can prolong or shorten the action potential duration in canine ventricular myocytes: dependence on blockade of K, Ca, and Na channels.
    Yao JA; Tseng GN
    J Cardiovasc Electrophysiol; 1997 Feb; 8(2):184-98. PubMed ID: 9048249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.
    Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
    Cardiology; 2007; 108(1):18-27. PubMed ID: 16960444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical possibilities for the development of novel antiarrhythmic drugs.
    Varró A; Biliczki P; Iost N; Virág L; Hála O; Kovács P; Mátyus P; Papp JG
    Curr Med Chem; 2004 Jan; 11(1):1-11. PubMed ID: 14754422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azimilide causes reverse rate-dependent block while reducing both components of delayed-rectifier current in canine ventricular myocytes.
    Gintant GA
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):945-53. PubMed ID: 9641481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined potassium and calcium channel antagonistic activities as a basis for neutral frequency dependent increase in action potential duration: comparison between BRL-32872 and azimilide.
    Bril A; Forest MC; Cheval B; Faivre JF
    Cardiovasc Res; 1998 Jan; 37(1):130-40. PubMed ID: 9539867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization.
    Varro A; Baláti B; Iost N; Takács J; Virág L; Lathrop DA; Csaba L; Tálosi L; Papp JG
    J Physiol; 2000 Feb; 523 Pt 1(Pt 1):67-81. PubMed ID: 10675203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro.
    Kovács A; Gyönös I; Magyar J; Bányász T; Nánási PP; Spedding M; Szénási G
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):78-88. PubMed ID: 11152377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azimilide dihydrochloride, a novel antiarrhythmic agent.
    Karam R; Marcello S; Brooks RR; Corey AE; Moore A
    Am J Cardiol; 1998 Mar; 81(6A):40D-46D. PubMed ID: 9537222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of new and potent methanesulfonanilide class III antiarrhythmic agents on myocardial refractoriness and contractility in isolated cardiac muscle.
    Baskin EP; Serik CM; Wallace AA; Brookes LM; Selnick HG; Claremon DA; Lynch JJ
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):406-14. PubMed ID: 1720841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B.
    Schreieck J; Wang Y; Gjini V; Korth M; Zrenner B; Schömig A; Schmitt C
    J Cardiovasc Electrophysiol; 1997 Dec; 8(12):1420-30. PubMed ID: 9436780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane activity of class III antiarrhythmic compounds; a comparison between ibutilide, d-sotalol, E-4031, sematilide and dofetilide.
    Lee KS; Tsai TD; Lee EW
    Eur J Pharmacol; 1993 Mar; 234(1):43-53. PubMed ID: 8472760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.